On November 21, 2023, Neuraxis (AMEX:NRXS) unveiled its quarterly financial report, revealing a distinct downward trend in their performance. The company experienced a loss of $(1.35) per share, marking a decline from $(1.14) per share during the corresponding period in the previous year. Additionally, their sales for the quarter plummeted to $477.46 thousand, showing a significant drop from $618.80 thousand in the same period last year. This translates to a worrisome 22.6% year-over-year decrease in revenue. These figures clearly indicate a decline in both earnings and sales for Neuraxis, underscoring the challenges they faced compared to the same period in the preceding year.
Updated on: 30/11/2023
Debt to equity ratio:
Price to earnings ratio:
Price to book ratio:
We did not find social sentiment data for this stock
There are no analysts data to display
NRXS Stock: Stable Price at $2.37 with High Trading Volume of 3,392 Shares
On November 21, 2023, NRXS stock had a previous close of $2.34 and opened at $2.37. Throughout the day, the stock’s price remained constant at $2.37. The trading volume for the day was 3,392 shares, which is higher than the average volume of 1,112 shares over the past three months.
NRXS Stock Performance on November 21, 2023: Uncertainty and Limited Information
NRXS Stock Performance on November 21, 2023
On November 21, 2023, NRXS stock exhibited a rather uncertain performance, with limited information available regarding its earnings per share and sales for the current quarter. As of now, there is no forecast data or recommendations provided to gauge the stock’s potential performance.
The lack of specific information regarding NRXS’s earnings per share and sales for the current quarter makes it difficult to assess the company’s financial health and growth prospects. Without these key metrics, investors and analysts are left without a clear understanding of the company’s profitability and revenue generation.
Furthermore, the reporting date for NRXS’s financial results is also listed as “TBD” or “to be determined.” This lack of a specific reporting date further adds to the uncertainty surrounding the stock’s performance on November 21, 2023.
Given the limited information available, it is crucial for investors to exercise caution and conduct thorough research before making any investment decisions related to NRXS stock. They should consider consulting with financial advisors or utilizing other reliable sources to gain a deeper understanding of the company’s financials, competitive position, and future prospects.
It is worth mentioning that stock performance can be influenced by various factors, including market conditions, industry trends, company-specific news or events, and macroeconomic indicators. Without specific data on NRXS’s earnings per share and sales, it is challenging to analyze these factors and their impact on the stock’s performance on November 21, 2023.
In conclusion, NRXS stock’s performance on November 21, 2023, remains uncertain due to the lack of available information regarding its earnings per share, sales, and reporting date. Investors should exercise caution and seek additional information from reliable sources before making any investment decisions.